We are live on
!
Find out more
ENZY
Enzymotec Ltd
ENZY
ENZY
Delisted
ENZY was delisted on the 10th of January, 2018.
21 hedge funds and large institutions have $50.3M invested in Enzymotec Ltd in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
13% less capital invested
Capital invested by funds: $58.1M → $50.3M (-$7.78M)
19% less funds holding
Funds holding: 26 → 21 (-5)
56% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 9
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Holders
21
Holders Change
-5
Holders Change %
-19.23%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
9
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$2.42M |
| 2 |
Renaissance Technologies
New York
|
+$85.8K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$21.4K |
| 4 |
State Street
Boston,
Massachusetts
|
+$3.17K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$833 |
Top Sellers
| 1 |
GA
Gagnon Advisors
New York
|
-$2.67M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$341K |
| 3 |
GS
Gagnon Securities
New York
|
-$234K |
| 4 |
LCM
Laurion Capital Management
New York
|
-$124K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$59K |
